Press Releases

NOXXON Pharma N.V. a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today it has entered into a material transfer agreement with the U.S. National Cancer Institute (NCI), of the National Institutes of Health (NIH), to further explore the effects of NOXXON’s lead compounds, the CXCL12 inhibitor NOX-A12 and the CCL2 inhibitor NOX-E36, individually and combined, on brain tumors. The research program will

Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies for chronic age-related diseases targeting senescent cells that drive cellular aging, today announced the appointments of Judith Campisi, Ph.D., Francesca Grisoni, Ph.D., and Mario Lacouture, M.D., to its Scientific Advisory Board (SAB). The SAB comprises experts in aging biology, AI, dermatology, drug discovery and development. “We are pleased to welcome Profs. Campisi, Lacoutur

Ascentage Pharma , a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it has released results from a Phase I study of the company's novel Bcl-2-selective inhibitor lisaftoclax (APG-2575) in Chinese patients with relapsed/refractory non-Hodgkin lymphoma (r/r NHL) at the 2022 European Hematology Association Hybrid Congress (EHA 2022). The EHA Congress is the largest gatheri

CPhI Conferences’ 11th Annual Innopack Pharma Confex presented by West Pharmaceutical Services commenced today with the focus on strengthening the pharmaceutical packaging industry. The two-day pharma confex  (9th and 10th June 2022) held at the Sahara Star, Mumbai was marked by the presence of key dignitaries including Dr. Hemant G Koshia, Commissioner, Food & Drugs Control Administration, Gujarat State, INDIA; CG Mr. Bart de Jong, Consulate General of the Kingdom of The Nethe

Cellbox Solutions is proud to launch the Cellbox 2.0 - the next generation of transportable incubators showcasing added features, improvements, and new software options. The company increased the self-sufficient runtime of the device to more than 48 hours, enabled collection of comprehensive shipment data via 8 different sensors, and upgraded the software and user interface to make the Cellbox 2.0 the best solution for worldwide live cell and organoid transportation, both in regulated and R&a

7 Hills Pharma LLC (“7 Hills” or “7HP”) has secured newly issued US patent claims that significantly expand the extent of the company’s intellectual property (IP) estate. By virtue of these new claims (issued patent no. 11,311,619), the 7HP IP estate now encompasses combinations of any integrin agonist with any antigen. Along with existing company IP broadly covering the landscape of small molecule integrin agonists, the new patent claims showcase 7HP’s lea

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it has been named a Top 10 Top Quality Assurance Services provider by Pharma Tech Outlook Europe. The award, shared in the special Quality Assurance Edition (May 2022) of Pharma Tech Outlook Europe magazine, lists the top ten companies providing the best Quality Assurance services for the pharmaceutical industry. AGC Biologics is the only CDMO to be included

DTG, the leading provider of industrial-strength power systems and mobile workstation solutions, today launched the Cleanroom PowerStation. The mobilized, battery-powered stainless steel workstation is designed for the rigorous data collection and quality control standards of Good Manufacturing Practice (GMP) for Class A cleanroom environments in Biopharma. The Cleanroom PowerStation was first designed for one of the world’s leading biopharma firms to comply with its sterile e

HMNC Brain Health , together with Develco pharma, today announced the dosing of the first patient in their second Phase 2 trial with oral prolonged-release Ketamine (KET01) for Treatment-Resistant Depression. HMNC is a global precision psychiatry biopharma company, pioneering the development of personalized therapies powered by its nascent AI platform and predictive companion diagnostics suite, leading to far shorter treatment durations, higher remission rates, and low side effects

Astellas Pharma Inc.  today announced the opening of a new late-stage clinical and commercial manufacturing facility in Sanford, N.C. The facility will allow the company to expand its resources and team to establish a robust, global supply chain and expand its therapeutic and geographic scope. "Our new manufacturing facility symbolizes our company's continued dedication to the advancement of novel life-changing gene therapies for patients with severe diseases and a sig